| Stage | CVNA | % of rev | ABG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $4.4B | 100.00% | CVNA ×1.82 |
| Gross profit | $1.5B | 18.92% | $732M | 16.57% | CVNA +2.3pp |
| Operating income | $714M | 8.88% | $207M | 4.68% | CVNA +4.2pp |
| Pre-tax income | $552M | 6.87% | $139M | 3.15% | CVNA +3.7pp |
| Net income | $483M | 6.01% | $105M | 2.38% | CVNA +3.6pp |
| Stage | CVNA | ABG | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $4.4B100.00% | CVNA ×1.82 |
| Gross profit | 18.92%$1.5B | 16.57%$732M | CVNA +2.3pp |
| Operating income | 8.88%$714M | 4.68%$207M | CVNA +4.2pp |
| Pre-tax income | 6.87%$552M | 3.15%$139M | CVNA +3.7pp |
| Net income |
| 6.01%$483M |
| 2.38%$105M |
| CVNA +3.6pp |
No disclosed counterparties: ABG.
None